Colon polyps
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Synonyms and keywords: Colonic polyps; intestinal polyps; colorectal polyps; adenomatous polyps; hyperplastic polyps; villous adenomas; serrated polyp; serrated adenoma; precancerous polyps
Overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
Colon polyps are unregulated growth of mucosal surface of the colon. The exact etiology is unclear. However, risk factors may contribute to the formation of polyps including age,family history, obesity, cigarette smoking, and alcohol consumption. There are four different types of polyps including inflammatory, hamartomatous, serrated, and adenomatous polyps, which have different pathogenesis. Inflammatory polyps are non-neoplastic polyps that occur following intestinal inflammation, infections, or ischemia. Hamartomatous polyp is an overgrowth of mature cells and connective tissue elements including smooth muscle, lamina propria, and cartilage, and fat which is covered by a hypertrophic epithelium. Serrated polyps include hyperplastic, sessile serrated and traditional serrated polyps. Hyperplastic polyps are the most common polyps. Hyperplastic polyp is infolding of the cryptepithelium that forms serration or saw-toothed appearance. Sessile serrated polyps are flask-shaped crypts, with dilatation and branching but not pedunculated. Traditional serrated adenomas are serrated polyps that are protuberant and pedunculated, which are located in left colon. Traditional adenoma also known as conventional polyps, are developed throughout the colon. They are the most prevalent polyps that have malignant potential. Colon polyps are incidentally found in colonoscopies and sigmoidoscopies. Polyps might grow gradually and cause symptoms including obstruction, bleeding, and changes in bowel habits. Some of them might progress to colorectal cancer. Colonoscopy and flexible sigmoidoscopy are diagnostic studies of choice to diagnose colon polyps. The mainstay of treatment for colon polyps is surgery. Aspirin is recommended to prevent recurrent polyps or conversion of colon polyps to colorectal cancer. Surgery is indicated for all colon polyps that are detected during screening for colorectal cancer. There are different surgical treatments for colon polyps including polypectomy, laparoscopic surgery and total proctocolectomy. All polyps must be sent to pathology laboratory for the biopsy. Regular exercise, healthy diet, smoking cessation, and reduced alcohol consumption might be helpful for preventing colon polyps. It is recommended to take aspirin, calcium and vitamin D to decrease the risk of colon polyps. According to guidelines for colonoscopysurveillance after screening and polypectomy by the US Multi-Society Task Force on colorectal cancer, surveillance and screening are more frequent after first or second adenomatous polyps or serrated polyps.
Historical Perspective
In 1895, the first sigmoidoscopy was developed to visualize the colon. Since then, it has been used to screen for colon polyps and colorectal cancer. In 1975, it was reported that adenomas are the precursors of colorectal cancer and hyperplastic polyps are non-neoplastic lesions. Since 1992, different pathways of polyp-cancer have been introduced, including molecular adenoma-carcinoma progression, mutator phenotype, serrated (neoplasia) pathway.
Classification
Colon polyps may be classified into two groups of neoplastic and nonneoplastic. Non-neoplastic polyps consist of inflammatory and hamartomatous polyps. Neoplastic polyps consist of serrated and adenomatous polyps. Adenomatous polyps may be classified into several subtypes based on endoscopic, histologic features and degree of dysplasia. Adenomas may be classified according to endoscopic features into four groups including sessile, pedunculated, flat, or depressed. Adenomas may be classified according to histologic features into three groups including tubular, tubulovillous, and villous.
Pathophysiology
Any form of unregulated growth in the colon may cause polyps. The exact etiology is unclear. However, risk factors may contribute to the formation of polyps. There are four different types of polyps including inflammatory, hamartomatous, serrated, and adenomatous polyps, which have different pathogenesis. Inflammatory polyps are non-neoplastic polyps that occur following intestinal inflammation, infections, or ischemia. Hamartomatous polyp is an overgrowth of mature cells and connective tissue elements including smooth muscle, lamina propria, and cartilage, and fat. They are covered by a hypertrophic epithelium. Serrated polyps are different polyps which have variable malignant potential. They include hyperplastic, sessile serrated and traditional serrated polyps. Hyperplastic polyps are the most common polyps. Hyperplastic polyp is infolding of the cryptepithelium that forms serration or saw-toothed appearance. Sessile serrated polyps are flask-shaped crypts, with dilatation and branching but not pedunculated. Traditional serrated adenomas are serrated polyps that are protuberant and pedunculated, which are located in left colon. Traditional adenoma also known as conventional polyps, are developed throughout the colon. They are the most prevalent polyps that have malignant potential.
Causes
The cause of colon polyps has not been identified.
Differentiating Colon Polyps from Other Diseases
Colon polyps might present solitary or multiple. Solitary colon polyps usually have no symptoms. Colon polyps must be differentiated from other genetic diseases that cause multiple polyps, such as Peutz–Jeghers syndrome, Cowden syndrome, Bannayan–Riley–Ruvalcaba syndrome, juvenile polyposis, and McCune–Albright syndrome.
Epidemiology and Demographics
The exact incidence and prevalence of colon polyps are unknown. Colon polyps are incidentally found in colonoscopies and sigmoidoscopies. However, the incidence of colon polyps is estimated to be 200,000 cases in the united states annually. The prevalence of colon polyps is between 10-25% in different screening studies. The incidence of colon polyps increases with age; the median age at diagnosis is 50 years. Colon polyps usually affect individuals of the African American race. Men are more commonly affected by colon polyps than women. Colon polyps is a common disease worldwide.
Risk Factors
Risk factors in the development of colon polyps may be environmental, genetic, and lifestyle behaviors. The most potent risk factor in the development of colon polyps is age. Other risk factors include family history, obesity, cigarette smoking, and alcohol consumption.
Screening
There is insufficient evidence to recommend routine screening for colon polyps. According to the guidelines screening for the colon polyps must be done earlier after the first colon polyps are discovered. Hyperplastic polyps have no malignant tendency and recommendation for the colonoscopy is similar to general population. Adenomatous and serrated polyps have neoplastic nature and must be followed every 3-5 years.
Natural History, Complications, and Prognosis
Colon polyps are very common in general population. They are usually found during screening colonoscopy. Polyps might grow gradually and cause symptoms including obstruction, bleeding, and changes in bowel habits. Some of them might progress to colorectal cancer. Therefore, it is advisable to resect all polyps that are found during colonoscopy and send the tissue biopsy for pathology. Prognosis of colon polyps is generally excellent. The presence of multiple polyps is associated with genetic disorders with a particularly poor prognosis.
Diagnosis
Diagnostic Study of Choice
Colonoscopy and flexible sigmoidoscopy are diagnostic studies of choice to diagnose colon polyps.
History and Symptoms
The majority of patients with colon polyps are asymptomatic. Patients with colon polyps may have a positive history of previous polyps. Family history of polyps might be positive. Colon polyps are incidentally found during screening for colon cancer. However, if the polyps are large, they might present with rectal bleeding and fatigue, change in bowel habits and stool color, and crampy abdominal pain.
Physical Examination
Patients with colon polyps usually have normal physical examination. Patients with large colon polyps might have few signs including abdominal tenderness in the lower abdomen, a palpable rectal mass on digital rectal exam, and pallor due to occult bleeding.
Laboratory Findings
Laboratory testing is usually normal among patients with colon polyps. However, some patients with colon polyps may have abnormal tests, including CBC and stool test, which is usually suggestive of gastrointestinal bleeding. They might present with anemia or positive fecal occult blood.
Electrocardiogram
There are no ECG findings associated with colon polyps.
X-ray
Double-contrast Barium enema may be helpful in the diagnosis of colon polyps. Colon polyps might be presented as an outgrowths with lobulation or indentation and filling defects on x-rays.
Echocardiography/Ultrasound
There are no echocardiography/ultrasound findings associated with colon polyps.
CT scan
CT scan with contrast and CT colonography or virtual colonoscopy may be helpful in the diagnosis of colon polyps. Outgrowths and filling defects are suggestive of colon polyps.
MRI
MRI may be helpful in the diagnosis of colon polyps. Diffusion-weighted magnetic resonance imaging (DWI) and MRI colonography are used to detect polyps.
Other Imaging Findings
Colonoscopic spectroscopy and narrow-band imaging (NBI) may be helpful in the diagnosis of colon polyps.
Other Diagnostic Studies
Colonoscopy is considered as a gold standard for evaluating intestine, diagnostic and therapeutic approaches. Tissue biopsy and polypectomy could be done during colonoscopy. Findings on a colonoscopy and flexible sigmoidoscopy suggestive of colon polyps include visual detection of an outgrowth. Colonoscopy has 0.02% mortality and 0.2% morbidity 0.2%. Colonoscopy has side effects including pain, risk of perforation and bleeding.
Treatment
Medical Therapy
The mainstay of treatment for colon polyps is surgery. Aspirin is recommended to prevent recurrent polyps or conversion of colon polyps to colorectal cancer.
Surgery
Surgery is the mainstay of treatment for colon polyps. Surgery is indicated for all colon polyps that are detected during screening for colorectal cancer. There are different surgical treatments for colon polyps including polypectomy, laparoscopic surgery and total proctocolectomy. All polyps must be sent to pathology laboratory for the biopsy.
Primary Prevention
Effective measures for the primary prevention of colon polyps include lifestyle changes, medications, and genetic counseling. Regular exercise, healthy diet, smoking cessation, and reduced alcohol consumption might be helpful for preventing colon polyps. It is recommended to take aspirin, calcium and vitamin D to decrease the risk of colon polyps.
Secondary Prevention
Effective measures for the secondary prevention of colon polyps include surveillance after finding polyps on routine screening. According to guidelines for colonoscopysurveillance after screening and polypectomy by the US Multi-Society Task Force on colorectal cancer, surveillance and screening are more frequent after first or second adenomatous polyps or serrated polyps. Hyperplastic polyps are considered benign and screening remains similar to general population.
References
Historical Perspective
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
In 1895, the first sigmoidoscopy was developed to visualize the colon. Since then, it has been used to screen for colon polyps and colorectal cancer. In 1975, it was reported that adenomas are the precursors of colorectal cancer and hyperplastic polyps are non-neoplastic lesions. Since 1992, different pathways of polyp-cancer have been introduced, including molecular adenoma-carcinoma progression, mutator phenotype, serrated (neoplasia) pathway.
Historical Perspective
- In 1895, the first rigid sigmoidoscope was developed at Hopkins by Kelly.[1]
- In 1927, Lockhart-Mummery and Dukes recognized the precancerous changes in the rectum and colon and identified the staging system for colorectal cancer.[2]
- In 1960, Hertz and Deddish reported using sigmoidoscopy to screen colorectal cancer with 90% survival rate followed for over 15 years.[1]
- In 1967, Greegor used guaiac card test to detect early-stage colorectal cancer.[3]
- In 1973, Wolff and Shinya used colonoscopy to remove polyps.[4]
- In 1975, Morson was the first who reported that adenomas are the precursors of colorectal cancer and hyperplastic polyps are non-neoplastic lesions.[5]
- In 1988, Vogelstein introduced molecular adenoma-carcinoma progression model which APC mutations are the initiator factors, known as a classic adenoma-carcinoma pathway.[6]
- In 1992, another pathway known as the mutator phenotype was discovered in HNPCC patients.[7]
- In 1993, the polyp-cancer sequence was accepted by the National Polyp Study.[8]
- In 1999, Jass demonstrated another pathway related to serrated polyps, known as “serrated (neoplasia) pathway.”[7]
Landmark Events in the Development of Treatment Strategies
- In 1973, Wolff and Shinya used colonoscopy to remove polyps.[4]
References
- ↑ 1.0 1.1 Winawer, Sidney J. (2015). “The History of Colorectal Cancer Screening: A Personal Perspective”. Digestive Diseases and Sciences. 60 (3): 596–608. doi:10.1007/s10620-014-3466-y. ISSN 0163-2116.
- ↑ Bonnington, Stewart N (2016). “Surveillance of colonic polyps: Are we getting it right?”. World Journal of Gastroenterology. 22 (6): 1925. doi:10.3748/wjg.v22.i6.1925. ISSN 1007-9327.
- ↑ Greegor, David H. (1967). “Diagnosis of Large-Bowel Cancer in the Asymptomatic Patient”. JAMA: The Journal of the American Medical Association. 201 (12): 943. doi:10.1001/jama.1967.03130120051012. ISSN 0098-7484.
- ↑ 4.0 4.1 Wolff, William I.; Shinya, Hiromi (1973). “Polypectomy Via the Fiberoptic Colonoscope”. New England Journal of Medicine. 288 (7): 329–332. doi:10.1056/NEJM197302152880701. ISSN 0028-4793.
- ↑ Muto T, Bussey HJ, Morson BC (1975). “The evolution of cancer of the colon and rectum”. Cancer. 36 (6): 2251–70. PMID 1203876.
- ↑ O’Brien, Michael J. (2007). “Hyperplastic and Serrated Polyps of the Colorectum”. Gastroenterology Clinics of North America. 36 (4): 947–968. doi:10.1016/j.gtc.2007.08.007. ISSN 0889-8553.
- ↑ 7.0 7.1 Rüschoff J, Aust D, Hartmann A (2007). “[Colorectal serrated adenoma: diagnostic criteria and clinical implications]”. Verh Dtsch Ges Pathol (in German). 91: 119–25. PMID 18314605.
- ↑ Winawer, Sidney J.; Zauber, Ann G.; Ho, May Nah; O’Brien, Michael J.; Gottlieb, Leonard S.; Sternberg, Stephen S.; Waye, Jerome D.; Schapiro, Melvin; Bond, John H.; Panish, Joel F.; Ackroyd, Frederick; Shike, Moshe; Kurtz, Robert C.; Hornsby-Lewis, Lynn; Gerdes, Hans; Stewart, Edward T. (1993). “Prevention of Colorectal Cancer by Colonoscopic Polypectomy”. New England Journal of Medicine. 329 (27): 1977–1981. doi:10.1056/NEJM199312303292701. ISSN 0028-4793.
Classification
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
Colon polyps may be classified into two groups of neoplastic and non-neoplastic. Non-neoplastic polyps consist of inflammatory and hamartomatous polyps. Neoplastic polyps consist of serrated and adenomatous polyps. Adenomatous polyps may be classified into several subtypes based on endoscopic and histologic features, and degree of dysplasia. Adenomas may be classified according to endoscopic features into four groups including sessile, pedunculated, flat, or depressed. Adenomas may be classified according to histologic features into three groups including tubular, tubulovillous, and villous.
Classification
- Colon polyps may be classified into several subtypes based on:[1][2][3][4][5]
- Malignancy potentials
- Endoscopic features
- Histologic features
- Degree of dysplasia
Colon polyps may be classified according to the NBI International Colorectal Endoscopic (NICE) classification into two types:[6][7]
| NICE criterion | Type 1 | Type 2 |
|---|---|---|
| Color | Same or lighter background | Darker background |
| Vessels | None, or isolated lacy vessels coursing across the lesion | Brown vessels surrounding the white center |
| Surface | Circular pattern with dark or white small spots surrounded by lighter mucosa | Oval, tubular, or branched white structures |
| Probable pathology | Hyperplastic | Adenoma |
Colon polyps may be classified according to malignancy potentials into two large groups:
- Non-neoplastic
- Inflammatory polyps
- Inflammatory pseudopolyps
- Prolapse type inflammatory polyps
- Myoglandular polyps
- Hamartomatous polyps
- Juvenile polyps
- Peutz-Jeghers syndrome
- Cronkhite-Canada syndrome
- Phosphatase and tensin homolog (PTEN) hamartoma tumor syndrome
- Inflammatory polyps
- Neoplastic
- Serrated polyps
- Hyperplastic polyps
- Traditional serrated adenomas
- Sessile serrated polyps
- Serrated polyposis syndrome
- Adenomatous polyps
- Serrated polyps
Adenomas may be classified according to endoscopic features into four groups:
- Sessile
- Pedunculated
- Flat
- Depressed
Adenomas may be classified according to histologic features into three groups:
- Tubular
- Villous
- Tubulovillous
Adenomas may be classified according to degree of dysplasia into two groups:
References
- ↑ Shussman, N.; Wexner, S. D. (2014). “Colorectal polyps and polyposis syndromes”. Gastroenterology Report. 2 (1): 1–15. doi:10.1093/gastro/got041. ISSN 2052-0034.
- ↑ Li SC, Burgart L (2007). “Histopathology of serrated adenoma, its variants, and differentiation from conventional adenomatous and hyperplastic polyps”. Arch. Pathol. Lab. Med. 131 (3): 440–5. doi:10.1043/1543-2165(2007)131[440:HOSAIV]2.0.CO;2. PMID 17516746.
- ↑ Bonnington, Stewart N (2016). “Surveillance of colonic polyps: Are we getting it right?”. World Journal of Gastroenterology. 22 (6): 1925. doi:10.3748/wjg.v22.i6.1925. ISSN 1007-9327.
- ↑ Ponugoti, Prasanna; Lin, Jingmei; Odze, Robert; Snover, Dale; Kahi, Charles; Rex, Douglas K. (2017). “Prevalence of sessile serrated adenoma/polyp in hyperplastic-appearing diminutive rectosigmoid polyps”. Gastrointestinal Endoscopy. 85 (3): 622–627. doi:10.1016/j.gie.2016.10.022. ISSN 0016-5107.
- ↑ O’Brien, Michael J. (2007). “Hyperplastic and Serrated Polyps of the Colorectum”. Gastroenterology Clinics of North America. 36 (4): 947–968. doi:10.1016/j.gtc.2007.08.007. ISSN 0889-8553.
- ↑ Hewett, David G.; Kaltenbach, Tonya; Sano, Yasushi; Tanaka, Shinji; Saunders, Brian P.; Ponchon, Thierry; Soetikno, Roy; Rex, Douglas K. (2012). “Validation of a Simple Classification System for Endoscopic Diagnosis of Small Colorectal Polyps Using Narrow-Band Imaging”. Gastroenterology. 143 (3): 599–607.e1. doi:10.1053/j.gastro.2012.05.006. ISSN 0016-5085.
- ↑ Rameshshanker, R.; Wilson, Ana (2016). “Electronic Imaging in Colonoscopy: Clinical Applications and Future Prospects”. Current Treatment Options in Gastroenterology. 14 (1): 140–151. doi:10.1007/s11938-016-0075-1. ISSN 1092-8472.
Pathophysiology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
Any form of unregulated growth in the colon may cause polyps. The exact etiology is unclear. However, risk factors may contribute to the formation of polyps. There are four different types of polyps including inflammatory, hamartomatous, serrated, and adenomatous polyps, which have different pathogenesis. Inflammatory polyps are non-neoplastic polyps that occur following intestinal inflammation, infections, or ischemia. Hamartomatous polyp is an overgrowth of mature cells and connective tissue elements including smooth muscle, lamina propria, and cartilage, and fat. They are covered by a hypertrophic epithelium. Serrated polyps are different polyps which have variable malignant potential. They include hyperplastic, sessile serrated and traditional serrated polyps. Hyperplastic polyps are the most common polyps. Hyperplastic polyp is infolding of the crypt epithelium that forms serration or saw-toothed appearance. Sessile serrated polyps are flask-shaped crypts, with dilatation and branching but not pedunculated. Traditional serrated adenomas are serrated polyps that are protuberant and pedunculated, which are located in left colon. Traditional adenoma also known as conventional polyps, are developed throughout the colon. They are the most prevalent polyps that have malignant potential.
Pathophysiology
- Any form of unregulated growth in the colon may cause polyps. The exact etiology is unclear. However, risk factors may contribute to the formation of polyps.[1][2][3][4]
- There are four different types of polyps including inflammatory, hamartomatous, serrated, and adenomatous polyps, which have different pathogenesis.
- The pathophysiology of colon polyps depends on the histological type.
{{#ev:youtube|oJU7CokNLZY}} {{#ev:youtube|7n5EnaLOV54}}
Inflammatory polyps
- Inflammatory polyps are non-neoplastic polyps that occur following intestinal inflammation, infections, or ischemia.[2][5]
- They mostly occur in patients with inflammatory bowel disease, mainly ulcerative colitis.
- They are considered as pseudopolyps which contain inflammatory infiltrations with distorted mucosa.
- It had no malignant potential. However, it is recommended to biopsy the lesion and surrounding mucosa.
- Microscopic pathology of biopsy shows mixture of normal, ulcerated, and regenerating mucosa which is surrounded by areas of mucosal loss.
Hamartomatous polyps
- Hamartomatous polyp is an overgrowth of mature cells and connective tissue elements including smooth muscle, lamina propria, and cartilage, and fat. They are covered by a hypertrophic epithelium.[6]
- They might be pedunculated, inflamed, or smooth polyps which are solitary or multiple.
- Solitary hamartomatous polyps, also known as juvenile polyps, can present more commonly in younger population.
- Solitary polyps has no significant risk of cancer. However, multiple polyps of the colon have a 10% risk of malignancy.
Serrated polyps
- Serrated polyps are different polyps which have variable malignant potential. They include hyperplastic, sessile serrated and traditional serrated polyps. They have various histopathologies and manifestations:
- Hyperplastic polyps are the most common polyps.
- They are small outpouching, less than 5 mm, which are located mostly in rectosigmoid area.
- Hyperplastic polyp is infolding of the crypt epithelium that forms serration or saw-toothed appearance.
- The molecular basis of this transformation is still unclear. However, it has been attributed to failure of apoptosis.
- BRAF mutations are associated with crypt serration.[7]
- There are three different subtypes of hyperplastic polyps based on degree of serration and content, including microvesicular type, goblet cell–rich type, and mucin-poor type.
- Sessile serrated polyps:
- Traditional serrated adenomas:
- They are protuberant and pedunculated polyps, less than 1.5 cm, which are located in left colon.[5]
- They have cytological dysplasia including nuclear transformation, irregular nuclear polarity, and serration.
- Cytological dysplasia causes crypts that are irregular and branching.
- Hyperplastic polyps are the most common polyps.
Adenomatous polyps
- Traditional adenoma also known as conventional polyps, are developed throughout the colon.
- They are the most prevalent polyps that have malignant potential.
- They have different gross appearances including pedunculated, sessile, flat, or depressed.
- They might have different histopathologies including tubular, villous, or tubulovillous.
Genetics
- The development of colon polyps is the result of multiple genetic mutations.
- Genetic mutations might cause hereditary polyps disorders.
- FAP is due to mutations in the following genes:
- APC gene, which is located on chromosome 5 in band q21 or band q22 (5q21-q22).
- MUTYH gene, which is located on chromosome 1 between bands p34.2 and p32.1 (5p34.3-p32.1).
- MYH-associated polyposis (MAP) is caused by mutations in the MYH gene.
- It is thought that Peutz-Jeghers syndrome is the result of deletion or partial deletion of STK11 (LBK1) gene, located on chromosome 19p13.3.
- It is caused by mutation in the APC gene located in chromosome 5q21 (band q21 on chromosome 5).
Serrated polyposis syndrome
- They develop multiple serrated adenomatous polyps in the upper part of the colon.
Familial juvenile polyposis
- It is an autosomal dominant disorder.
- It increases risk of colorectal cancer.
- It has extra-colonic tumors.
- There has been some association with the following genes:
- SMAD4 on chromosome 18.
- PTEN on chromosome 10.
Gross Pathology
- On gross pathology, outpouching, pedunculated or flat lesions are characteristic findings of colon polyps.
- On gross pathology, colon polyps may have a short or long stalk.
- The polyp might have hemorrhagic stalk and colon wall with pale ribbon of mucosal covering.
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Microscopic Pathology
- On microscopic histopathological analysis, serration of the luminal surface and normal nuclei are characteristic findings of hyperplastic polyps.
- On microscopic histopathological analysis, branched tubular glands are characteristic findings of tubular adenoma.
- On microscopic histopathological analysis, long finger-like projections are characteristic findings of villous adenoma.
- On microscopic histopathological analysis, branched and dilated glands, no cytological atypia, eosinophilic cytoplasm, and luminal epithelial tufting are characteristic findings of sessile serrated adenoma.



References
- ↑ Rüschoff J, Aust D, Hartmann A (2007). “[Colorectal serrated adenoma: diagnostic criteria and clinical implications]”. Verh Dtsch Ges Pathol (in German). 91: 119–25. PMID 18314605.
- ↑ 2.0 2.1 Shussman, N.; Wexner, S. D. (2014). “Colorectal polyps and polyposis syndromes”. Gastroenterology Report. 2 (1): 1–15. doi:10.1093/gastro/got041. ISSN 2052-0034.
- ↑ Singh, Rajvinder; Zorrón Cheng Tao Pu, Leonardo; Koay, Doreen; Burt, Alastair (2016). “Sessile serrated adenoma/polyps: Where are we at in 2016?”. World Journal of Gastroenterology. 22 (34): 7754. doi:10.3748/wjg.v22.i34.7754. ISSN 1007-9327.
- ↑ Kahi, Charles J.; Vemulapalli, Krishna C.; Snover, Dale C.; Abdel Jawad, Khaled H.; Cummings, Oscar W.; Rex, Douglas K. (2015). “Findings in the Distal Colorectum Are Not Associated With Proximal Advanced Serrated Lesions”. Clinical Gastroenterology and Hepatology. 13 (2): 345–351. doi:10.1016/j.cgh.2014.07.044. ISSN 1542-3565.
- ↑ 5.0 5.1 Li SC, Burgart L (2007). “Histopathology of serrated adenoma, its variants, and differentiation from conventional adenomatous and hyperplastic polyps”. Arch. Pathol. Lab. Med. 131 (3): 440–5. doi:10.1043/1543-2165(2007)131[440:HOSAIV]2.0.CO;2. PMID 17516746.
- ↑ Zbuk KM, Eng C (2007). “Hamartomatous polyposis syndromes”. Nat Clin Pract Gastroenterol Hepatol. 4 (9): 492–502. doi:10.1038/ncpgasthep0902. PMID 17768394.
- ↑ Kambara T, Simms LA, Whitehall VL, Spring KJ, Wynter CV, Walsh MD, Barker MA, Arnold S, McGivern A, Matsubara N, Tanaka N, Higuchi T, Young J, Jass JR, Leggett BA (2004). “BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum”. Gut. 53 (8): 1137–44. doi:10.1136/gut.2003.037671. PMC 1774130. PMID 15247181.
- ↑ Bettington, Mark; Walker, Neal; Clouston, Andrew; Brown, Ian; Leggett, Barbara; Whitehall, Vicki (2013). “The serrated pathway to colorectal carcinoma: current concepts and challenges”. Histopathology. 62 (3): 367–386. doi:10.1111/his.12055. ISSN 0309-0167.
- ↑ O’Connell, Brendon M; Crockett, Seth D (2017). “The clinical impact of serrated colorectal polyps”. Clinical Epidemiology. Volume 9: 113–125. doi:10.2147/CLEP.S106257. ISSN 1179-1349.
- ↑ “File:Image of resected colon segment with cancer & 4 nearby polyps plus schematic of field defects with sub-clones.jpg – Wikimedia Commons”.
Causes
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
The cause of colon polyps has not been identified. To review risk factors for the development of colon polyps, click here.
Causes
- The exact etiology of colon polyps is unknown.[1][2]
- There are many genetic and environmental risk factors which increase the risk of development of colon polyps.
- To review risk factors for the development of colon polyps, click here.
References
- ↑ Li SC, Burgart L (2007). “Histopathology of serrated adenoma, its variants, and differentiation from conventional adenomatous and hyperplastic polyps”. Arch. Pathol. Lab. Med. 131 (3): 440–5. doi:10.1043/1543-2165(2007)131[440:HOSAIV]2.0.CO;2. PMID 17516746.
- ↑ Shussman, N.; Wexner, S. D. (2014). “Colorectal polyps and polyposis syndromes”. Gastroenterology Report. 2 (1): 1–15. doi:10.1093/gastro/got041. ISSN 2052-0034.
Differentiating Colon Polyps from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
Colon polyps might present solitary or multiple. Solitary colon polyps usually have no symptoms. Colon polyps must be differentiated from other genetic diseases that cause multiple polyps, such as Peutz–Jeghers syndrome, Cowden syndrome, Bannayan–Riley–Ruvalcaba syndrome, juvenile polyposis, and McCune–Albright syndrome.
Differentiating Colon Polyps from other Diseases
Colon polyps must be differentiated from the following diseases:[1][2]
- Peutz–Jeghers syndrome
- Cowden syndrome
- Cronkhite–Canada syndrome
- Bannayan–Riley–Ruvalcaba syndrome
- Juvenile polyposis
- McCune–Albright syndrome
Differential diagnosis according to polys:
| Diseases | History and Symptoms | Physical Examination | Laboratory Findings | Other Findings | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abdominal Pain | Rectal Bleeding | Hyperpigmentation | Fatigue | Abdominal Tenderness | Hyperpigmentation | Anemia | Gene(s) | Sertoli Cell Tumors | Gastrointestinal Tumors | Cancers | ||
| Juvenile Polyposis Syndrome | + | _ | – | + | – | – | – |
|
– | _ | ||
| Cowden Syndrome | – | – | – | – | – | – | ||||||
| Carney Syndrome | – | – | – | – | – | ++ | ||||||
| Familial Adenomatous Polyposis | + | + | – | + | +/– | – | + | – |
|
|||
| Hereditary Non–Polyposis Colon Cancer | – | + | – | + | +/– | – | + | – | ||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
References
- ↑ Buck, J L; Harned, R K; Lichtenstein, J E; Sobin, L H (1992). “Peutz-Jeghers syndrome”. RadioGraphics. 12 (2): 365–378. doi:10.1148/radiographics.12.2.1561426. ISSN 0271-5333.
- ↑ “Peutz-Jeghers Syndrome – GeneReviews® – NCBI Bookshelf”.
Epidemiology and Demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
The exact incidence and prevalence of colon polyps are unknown. Colon polyps are incidentally found in colonoscopies and sigmoidoscopies. However, the incidence of colon polyps is estimated to be 200,000 cases in the united states annually. The prevalence of colon polyps is between 10,000-25,000 in 100,000 screening studies. The incidence of colon polyps increases with age; the median age at diagnosis is 50 years. Colon polyps usually affect individuals of the African American race. Men are more commonly affected by colon polyps than women. Colon polyps is a common disease worldwide.
Epidemiology and Demographics
Incidence
- The incidence of colon polyps is estimated to be 200,000 cases in the united states annually.
- The cumulative incidence of polyps in 3 years after normal flexible sigmoidoscopy is 7%.[1]
- The cumulative incidence of polyps in 3 years after normal colonoscopy is 27%.[1]
Prevalence
- The prevalence of colon polyps is 10,000 in 100,000 sigmoidoscopy studies.[1]
- The prevalence of colon polyps is 25,000 in 100,000 colonoscopy studies.[1]
- The prevalence of hyperplastic colon polyps in autopsy studies is between 7,000-40,000 in 100,000 in individuals younger than 50 years of age.[2]
- The prevalence of hyperplastic colon polyps in autopsy studies is between 20,000-40,000 in individuals older than 50 years of age.[2]
Age
- The incidence of colon polyps increases with age; the median age at diagnosis is 50 years.
- Colon polyps commonly affects individuals older than 50 years of age.
Race
- Colon polyps usually affect individuals of the African American race.[3]
Gender
- Men are more commonly affected by colon polyps than women.[3]
Region
- Colon polyps is a common disease worldwide.
References
- ↑ 1.0 1.1 1.2 1.3 Giacosa A, Frascio F, Munizzi F (2004). “Epidemiology of colorectal polyps”. Tech Coloproctol. 8 Suppl 2: s243–7. doi:10.1007/s10151-004-0169-y. PMID 15666099.
- ↑ 2.0 2.1 Liljegren A, Lindblom A, Rotstein S, Nilsson B, Rubio C, Jaramillo E (2003). “Prevalence and incidence of hyperplastic polyps and adenomas in familial colorectal cancer: correlation between the two types of colon polyps”. Gut. 52 (8): 1140–7. PMC 1773751. PMID 12865272.
- ↑ 3.0 3.1 Lieberman, David A. (2008). “Prevalence of Colon Polyps Detected by Colonoscopy Screening in Asymptomatic Black and White Patients”. JAMA. 300 (12): 1417. doi:10.1001/jama.300.12.1417. ISSN 0098-7484.
Risk Factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
Risk factors in the development of colon polyps may be environmental, genetic, and lifestyle behaviors. The most potent risk factor in the development of colon polyps is age. Other risk factors include family history, obesity, cigarette smoking, and alcohol consumption.
Risk Factors
- Risk factors in the development of colon polyps may be modifiable or nonmodifiable factors.[1][2][3][4]
- Risk factors in the development of colon polyps may be environmental, genetic, and lifestyle behaviors.
- The most potent risk factor in the development of colon polyps is age.
- Other risk factors include family history, obesity, cigarette smoking, and alcohol consumption.
Common Risk Factors
- Common risk factors in the development of colon polyps include:
- Non-modifiable
- Age
- Race
- Past history of colon polyps
- Family history
- Inflammatory bowel disease
- Modifiable lifestyle behavior
- Cigarette smoking
- Alcohol abuse
- Obesity
- Lack of exercise
- Diet high in red meats and processed meats
- Low fiber intake
- Low calcium intake
- Low folate intake
- Type 2 diabetes mellitus
- Non-modifiable
References
- ↑ O’Brien, Michael J. (2007). “Hyperplastic and Serrated Polyps of the Colorectum”. Gastroenterology Clinics of North America. 36 (4): 947–968. doi:10.1016/j.gtc.2007.08.007. ISSN 0889-8553.
- ↑ Martínez ME, McPherson RS, Levin B, Glober GA (1997). “A case-control study of dietary intake and other lifestyle risk factors for hyperplastic polyps”. Gastroenterology. 113 (2): 423–9. PMID 9247459.
- ↑ Morimoto LM, Newcomb PA, Ulrich CM, Bostick RM, Lais CJ, Potter JD (2002). “Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential?”. Cancer Epidemiol. Biomarkers Prev. 11 (10 Pt 1): 1012–8. PMID 12376501.
- ↑ O’Connell BM, Crockett SD (2017). “The clinical impact of serrated colorectal polyps”. Clin Epidemiol. 9: 113–125. doi:10.2147/CLEP.S106257. PMC 5327852. PMID 28260946.
Screening
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
There is insufficient evidence to recommend routine screening for colon polyps. According to the guidelines screening for the colon polyps must be done earlier after the first colon polyps are discovered. Hyperplastic polyps have no malignant tendency and recommendation for the colonoscopy is similar to general population. Adenomatous and serrated polyps have neoplastic nature and must be followed every 3-5 years.
Screening
- There is insufficient evidence to recommend routine screening for colon polyps in general population.
- According to guidelines for colonoscopy surveillance after screening and polypectomy by the US Multi-Society Task Force on Colorectal Cancer, recommendations for surveillance and screening are as follows:[1][2][3]
| Baseline colonoscopy | Recommendation | ||
|---|---|---|---|
| No polyps | Colonoscopy every 10 years | ||
| Polyps | Hyperplastic polyps | Size <10 mm | Colonoscopy every 10 years |
| Adenomatous polyps | 1-2 tubular adenomas <10 mm | Colonoscopy every 5-10 years | |
| 3-10 tubular adenomas <10 mm | Colonoscopy every 3 years | ||
| >10 adenomas | Colonoscopy <3 years | ||
| Tubular adenomas ≥10 mm | Colonoscopy every 3 years | ||
| Villous adenomas | Colonoscopy every 3 years | ||
| Adenoma with high grade dysplasia | Colonoscopy every 3 years | ||
| No adenoma after first low-risk adenoma | Colonoscopy every 10 years | ||
| No adenoma after first high-risk adenoma | Colonoscopy every 5 years | ||
| Second adenomatous polyps | Second low-risk adenoma | Colonoscopy after 5 years | |
| High-risk adenoma following low-risk adenoma | Colonoscopy every 3 years | ||
| Low-risk adenoma following high-risk adenoma | Colonoscopy after 5 years | ||
| Second high-risk adenoma | Colonoscopy every 3 years | ||
| Serrated polyps | Sessile serrated polyp(s) <10 mm with no dysplasia | Colonoscopy every 5 years | |
| Sessile serrated polyp(s) ≥10 mm | Colonoscopy every 3 years | ||
| Sessile serrated polyp with dysplasia | Colonoscopy every 3 years | ||
| Traditional serrated adenoma | Colonoscopy every 3 years | ||
| Serrated polyposis syndrome | Colonoscopy every year | ||
References
- ↑ Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR (2012). “Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer”. Gastroenterology. 143 (3): 844–857. doi:10.1053/j.gastro.2012.06.001. PMID 22763141.
- ↑ National Guideline Clearinghouse (NGC). Guideline summary: Follow-up of colorectal polyps or cancer. In: National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2013 Jan 16. [cited 2017 Dec 28]. Available: https://www.guideline.gov
- ↑ Rex DK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Levin TR, Lieberman D, Robertson DJ (2017). “Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer”. Am. J. Gastroenterol. 112 (7): 1016–1030. doi:10.1038/ajg.2017.174. PMID 28555630.
Natural History, Complications and Prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
Colon polyps are very common in general population. They are usually found during screening colonoscopy. Polyps might grow gradually and cause symptoms including obstruction, bleeding, and changes in bowel habits. Some of them might progress to colorectal cancer. Therefore, it is advisable to resect all polyps that are found during colonoscopy and send the tissue biopsy for pathology. Prognosis of colon polyps is generally excellent. The presence of multiple polyps is associated with genetic disorders with a particularly poor prognosis.
Natural History, Complications, and Prognosis
Natural History
- Colon polyps are very common in general population.[1]
- They are usually found during screening colonoscopy.[2]
- Polyps might grow gradually and cause symptoms including obstruction, bleeding, and changes in bowel habits.
- Some of them might have malignant potential.
- If left untreated, it may progress to develop colorectal cancer. The progression from an adenomatous polyp to colorectal cancer may take 10-15 years.
- All polyps are recommended to be resected.
Complications
- Gastrointestinal bleeding
- Bleeding following polypectomy
Prognosis
- Prognosis of colon polyps is generally excellent.[1]
- The presence of multiple polyps is associated with genetic disorders with a particularly poor prognosis.
- Colon polyps that are associated with BRAF and KRAS mutations have a poor prognosis.[4] This study also found no increase in mortality if 3 or more adenomas (RR = 1.4 [95% CI, 0.6 to 3.0]) or polyps larger than 1 cm
| Cancer cases after 13 years
% (n) |
Cancer incidence rates
(per 10 000 person-years of observation) |
Cancer mortality compared to
persons with no adenoma (relative risk) | |
|---|---|---|---|
| No adenoma
n = 94,248 |
< 0.1% (71) | 7.1 | NA |
| Nonadvanced adenoma
n = 65,650 |
< 0.1% (55) | 9.1 | 1.2
(95% CI, 0.5-2.7) |
| Advanced adenoma
n = 34,993 (≥1 cm, high-grade dysplasia, or tubulovillous or villous histology) |
0.2% (70) | 20 | 2.6
(95% CI, 1.2-5.7) |
References
- ↑ 1.0 1.1 Huang, Christopher S; Farraye, Francis A; Yang, Shi; O’Brien, Michael J (2010). “The Clinical Significance of Serrated Polyps”. The American Journal of Gastroenterology. 106 (2): 229–240. doi:10.1038/ajg.2010.429. ISSN 0002-9270.
- ↑ 2.0 2.1 Bonnington, Stewart N (2016). “Surveillance of colonic polyps: Are we getting it right?”. World Journal of Gastroenterology. 22 (6): 1925. doi:10.3748/wjg.v22.i6.1925. ISSN 1007-9327.
- ↑ Shussman, N.; Wexner, S. D. (2014). “Colorectal polyps and polyposis syndromes”. Gastroenterology Report. 2 (1): 1–15. doi:10.1093/gastro/got041. ISSN 2052-0034.
- ↑ Bettington, Mark; Walker, Neal; Clouston, Andrew; Brown, Ian; Leggett, Barbara; Whitehall, Vicki (2013). “The serrated pathway to colorectal carcinoma: current concepts and challenges”. Histopathology. 62 (3): 367–386. doi:10.1111/his.12055. ISSN 0309-0167.
- ↑ Click B, Pinsky PF, Hickey T, Doroudi M, Schoen RE (2018). “Association of Colonoscopy Adenoma Findings With Long-term Colorectal Cancer Incidence”. JAMA. 319 (19): 2021–2031. doi:10.1001/jama.2018.5809. PMID 29800214.
Diagnosis
Diagnosis
Diagnostic study of choice | History and Symptoms | Physical Examination | Electrocardiogram | Laboratory Findings | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Diagnostic Studies | Other Imaging Findings
Treatment
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH









